SCHEDULE: FMR LLC Discloses 8.2% Stake in Roivant Sciences
Beneficial Ownership Disclosure
FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, reporting beneficial ownership of 8.2% of Roivant Sciences Ltd.'s common stock.
Summary
- FMR LLC and Abigail P. Johnson collectively beneficially own 55,509,280.97 shares of Roivant Sciences Ltd. common stock.
- This ownership represents 8.2% of the total outstanding common stock of Roivant Sciences Ltd.
- FMR LLC holds sole voting power over 55,467,163 shares and sole dispositive power over 55,509,280.97 shares.
- Abigail P. Johnson holds sole dispositive power over 55,509,280.97 shares, with no sole or shared voting power.
- The filing is an Amendment No. 1 to a Schedule 13G, indicating an update to a previously reported beneficial ownership position.
- The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.
Sentiment
Score: 6
Explanation: The filing indicates a significant beneficial ownership stake by a major institutional investor, FMR LLC, and its principal, Abigail P. Johnson, in Roivant Sciences Ltd. While a routine disclosure, a substantial institutional holding can be viewed as a positive signal of investor confidence.
Positives
- FMR LLC, a prominent investment management firm, holds a significant 8.2% beneficial ownership stake in Roivant Sciences Ltd., which can be interpreted as a vote of confidence from a major institutional investor.
Negatives
- The filing does not present any negative operational or financial aspects of Roivant Sciences Ltd.
Risks
- The filing does not detail specific operational or financial risks related to Roivant Sciences Ltd.
Future Outlook
NA
Industry Context
NA
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Ownership Structure Disclosure | Disclosure of the Johnson family's predominant ownership of Series B voting common shares of FMR LLC, representing 49% of voting power, and a shareholders' voting agreement for Series B shares. | NA | Clarifies the ultimate control structure of the reporting entity, FMR LLC, and its affiliates, indicating that the Johnson family may be deemed a controlling group with respect to FMR LLC under the Investment Company Act of 1940. |
Related Party Transactions
- The filing details the ownership structure of FMR LLC, noting that members of the Johnson family, including Abigail P. Johnson, are predominant owners of Series B voting common shares, representing 49% of FMR LLC's voting power.
- A shareholders' voting agreement among Series B shareholders ensures all Series B voting common shares are voted in accordance with the majority vote, potentially deeming the Johnson family a controlling group with respect to FMR LLC under the Investment Company Act of 1940.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional holder's stake, which can influence market perception and liquidity.
- Company Management: Awareness of a large, passive institutional holder, though the filing states the holding is not for influencing control.
Key Dates
| Date | Description |
|---|---|
| 05/23/2023 | Effective date of Power of Attorney for Richard Bourgelas, authorizing signatures on behalf of FMR LLC and Abigail P. Johnson. |
| 08/08/2023 | Date of previous Schedule 13G filing by FMR LLC, referenced for Power of Attorney accession number. |
| 06/30/2025 | Date of event which requires filing of this statement, representing the reporting period end for beneficial ownership. |
| 08/05/2025 | Filing date of this Schedule 13G Amendment No. 1. |
Keywords
Roivant Sciences, FMR LLC, Abigail P. Johnson, Schedule 13G, beneficial ownership, common stock, institutional investor, SEC filing, biotechnology
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.